Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAU 2025 | EU targets for vaccine preventable cancers caused by HPV

Peter Baker, Global Action on Men’s Health, London, UK, comments on gender-neutral vaccinations for human papillomavirus (HPV). In reinforcement of the ‘Europe’s Beating Cancer Plan’ in 2024, the European Union (EU) council recommends all young people should be offered the HPV vaccine, targeting 90% vaccination in females and a significant increase in males. These recommendations are a huge step forward for vaccine-preventable cancers and other conditions, although more work is still required to reach these goals. This interview took place at the 2025 European Association of Urology (EAU) Congress in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.